You have 7 free searches left this month | for more free features.

Lipoprotein

Showing 26 - 50 of 5,508

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Categories and Attaining LDL-C Targets in Middle Eastern Adults

Not yet recruiting
  • Atherosclerotic Cardiovascular Risk
  • Low-density-lipoprotein (LDL) Cholesterol
    • (no location specified)
    Feb 16, 2023

    Lipoprotein Composition and Function in Pediatric Psoriasis

    Recruiting
    • Psoriasis
    • Fasting blood draw for lipid assessments
    • Chicago, Illinois
      Ann & Robert H. Lurie Children's Hospital of Chicago
    Apr 4, 2022

    Hyper-low-density Lipoprotein (LDL) Cholesterolemia Trial in Izumisano-shi (180mg of ETC-1002(bempedoic acid), Placebo)

    Recruiting
    • Hyper-low-density Lipoprotein (LDL) Cholesterolemia
    • 180mg of ETC-1002(bempedoic acid)
    • Placebo
    • Izumisano-shi, Japan
      Rinku General Medical Center
    Jan 4, 2023

    Lipid and Lipoprotein Dysregulation in Sepsis

    Recruiting
    • Sepsis
    • Shock, Septic
      • Jacksonville, Florida
        University of Florida
      Jan 10, 2022

      Cholesterol; Metabolic Disorder, Lipoproteinemia Trial in Nantes (infusion of tracer [5,5,5-2H3] -L-leucine)

      Completed
      • Cholesterol; Metabolic Disorder
      • Lipoproteinemia
      • infusion of tracer [5,5,5-2H3] -L-leucine
      • Nantes, France
        Nantes University Hospital
      Feb 22, 2022

      Hemorrhagic Stroke Trial in Shenyang (DELP)

      Recruiting
      • Hemorrhagic Stroke
      • DELP
      • Shenyang, China
        Department of Neurology, General Hospital of Northern Theater Co
      Jan 27, 2022

      Lipoproteinemia, Apheresis Related Complication, Cardiovascular Diseases Trial in Dresden (Dextran sulfate absorption

      Recruiting
      • Lipoproteinemia
      • +2 more
      • Dextran sulfate absorption (LIPOSORBER® D - Kaneka Pharma Europe NV)
      • +3 more
      • Dresden, Germany
        Carl Gustav Carus University Hospital Dresden, Technische Univer
      Dec 20, 2021

      Hypertriglyceridemia Trial in Sioux Falls (Lovaza)

      Completed
      • Hypertriglyceridemia
      • Sioux Falls, South Dakota
        Sanford Research/USD
      Sep 23, 2021

      Serum Adropin to Testosterone and Adiponectin in Obese Men

      Completed
      • Obesity
      • Dyslipidemias
      • lipid profile: Total cholesterol (TC), triglycerides (TG), low density lipoprotein (LDL) and high density lipoprotein (HDL))
      • +3 more
      • Aswan, Egypt
        Aswan University Hospital
      Feb 14, 2022

      Dyslipidemias, Obesity Trial in Storrs (Milk Polar Lipid-Rich Dairy Powder, Dairy Powder)

      Not yet recruiting
      • Dyslipidemias
      • Obesity
      • Milk Polar Lipid-Rich Dairy Powder
      • Dairy Powder
      • Storrs, Connecticut
        University of Connecticut
      Jan 18, 2023

      Hyper-low-density Lipoprotein (LDL) Cholesterolemia Trial in Izumisano-shi (180mg of ETC-1002(bempedoic acid))

      Recruiting
      • Hyper-low-density Lipoprotein (LDL) Cholesterolemia
      • 180mg of ETC-1002(bempedoic acid)
      • Izumisano-shi, Japan
        Rinku General Medical Center
      Jan 13, 2023

      Atherosclerosis Trial in Tel HaShomer

      Recruiting
      • Atherosclerosis
        • Tel HaShomer, Israel
          Lipid center
        Sep 26, 2021

        Lp(a) With CCTA Assessed Parameters and Clinical Outcomes

        Recruiting
        • Coronary Artery Disease
        • Coronary CTA
        • Shanghai, China
          Shanghai Zhongshan Hospital
        Apr 4, 2022

        Lipid Profile in Acute Coronary Syndrome

        Not yet recruiting
        • Acute Coronary Syndrome
        • Triglycerides/high density lipoprotein ratio
        • (no location specified)
        Nov 17, 2021

        Lipid Disorder, Triglycerides High, Dyslipidemias Trial in Philadelphia (Icosapent Ethyl 1000 MG [Vascepa])

        Completed
        • Lipid Disorder
        • +2 more
        • Icosapent Ethyl 1000 MG [Vascepa]
        • Philadelphia, Pennsylvania
          Perelman School of Medicine at the University of Pennsylvania
        Oct 15, 2021

        Hyperlipemia, Mixed, ASCVD Trial in Boston (Alert)

        Recruiting
        • Hyperlipemia, Mixed
        • ASCVD
        • Alert
        • Boston, Massachusetts
          Brigham and Women's Hospital
        Oct 21, 2021

        LDL Hyperlipoproteinemia, Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia, Triglyceride Storage Type I or II Disease

        Not yet recruiting
        • LDL Hyperlipoproteinemia
        • +2 more
        • omega-3 fatty acids
        • Placebo
        • Novosibirsk, Novosibisk Region, Russian Federation
          Center of New Medical Technologies
        Nov 30, 2023

        Hyperlipidemias, Dyslipidemias, Elevated Lp(a) Trial in Worldwide (SLN360, Placebo)

        Recruiting
        • Hyperlipidemias
        • +2 more
        • Jacksonville, Florida
        • +6 more
        Mar 18, 2022

        Oxidized Low Density Lipoprotein Trial in Fort Lauderdale (Cardio formulation, Placebo)

        Terminated
        • Oxidized Low Density Lipoprotein
        • Cardio formulation
        • Placebo
        • Fort Lauderdale, Florida
          Lfie Extension Clinical Reseach, Inc.
        Jan 12, 2023

        Lipoprotein Metabolism, PCSK9, Proteomics Trial run by the NHLBI (EPA-rich fish oil, DHA-rich fish oil)

        Completed
        • Lipoprotein Metabolism
        • +2 more
        • EPA-rich fish oil
        • DHA-rich fish oil
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Jun 25, 2021

        Low-density Lipoprotein Cholesterol Reduction With

        Recruiting
        • Acute Coronary Syndrome
        • Dyslipidemias
        • Banja Luka, Republic Of Srpska, Bosnia and Herzegovina
          University Clinical Centre of the Republic of Srpska
        Oct 17, 2021

        Low-density Lipoprotein Cholesterol Levels in Coronary Heart

        Completed
        • Hypercholesterolemia
        • (no location specified)
        Feb 7, 2022

        Dyslipidemia, Atherosclerosis, Acute Coronary Syndrome Trial in Dallas (RVX000222, Placebo)

        Completed
        • Dyslipidemia
        • +3 more
        • Dallas, Texas
          Covance Clinical Research Unit, Inc.
        Nov 1, 2022

        Coronary Artery Disease, Diabetes, Metabolic Syndrome Trial in Storrs (Consume 2 eggs with spinach per day, Egg Subsitute with

        Completed
        • Coronary Artery Disease
        • +2 more
        • Consume 2 eggs with spinach per day
        • Egg Subsitute with spinach per day
        • Storrs, Connecticut
          Department of Nutritional Sciences
        Nov 1, 2022

        HDL Trial in Nashville (CardioLux™HDL, Placebo)

        Active, not recruiting
        • HDL
        • CardioLux™HDL
        • Placebo
        • Nashville, Tennessee
          Hypertension Institute
        Apr 4, 2022